Executive Summary posted January 12, 2009 by Cheryl Smith, Laura L Summers
Executive Summary: How Medicare's Drug Pricing Can Hurt R&D
Given the sheer enormity of the growing Medicare program,
Members of Congress and the new Administration should realize that
any decisions they make regarding Medicare drug pricing could have
an enormous impact on pharmaceutical research and development. This
in turn would affect the quality of care for the baby boom
generation, parts of which will begin retiring in…
Backgrounder posted January 12, 2009 by Cheryl Smith, Laura L Summers
How Medicare's Drug Pricing Can Hurt R&D
Given the sheer enormity of the growing Medicare program,
Members of Congress and the Administration should realize that
any decisions they make regarding Medicare drug pricing could have
an enormous impact on pharmaceutical research and
development. This in turn would affect the quality of care for
the baby boom generation, parts of which will begin retiring…
WebMemo posted August 29, 2007 by Cheryl Smith
The House SCHIP Bill: Enlisting States as Agents of GovernmentDependency
States would become instruments for expanding dependency on the
federal government under the House-passed Children's Health and
Medicare Protection Act (H.R. 3162).[1] Legislation to reauthorize
the State Children's Health Insurance Program (SCHIP) is now headed
to House-Senate conference.
If enacted in its current form, the House bill would usher in a
major…
WebMemo posted August 1, 2007 by Cheryl Smith, Robert E. Moffit, Ph.D.
The House SCHIP Bill: Cutting Medicare, Undercutting Private Coverage, and Expanding Dependency
Congress is debating the future health care of millions of
Americans, and its decisions will affect families and children,
Medicare beneficiaries, and taxpayers for years to come. The
465-page bill favored by House leadership, The Children's Health
and Medicare Protection Act (H.R. 3162), greatly expands dependency
of millions of Americans on government health care,…